New Zealand community pharmacists'experiences in collecting information from purchasers of pseudoephedrine-containing products:findings from a qualitative study

摘要

Methylamphetamine has become well established in the New Zealand illicit drug market and recent research has identified its widespread availability.Much of the methylamphetamine is produced locally in clandestine laboratories and there has been a significant increase in the number of such laboratories detected over recent years.Pseudoephedrine is currently the main precursor used in the manufacture of methylamphetamine and is an ingredient of many over-the-counter cough and cold medicines.In New Zealand,such products are available only from registered pharmacies ("in either slow release form or in preparations containing not more than 60mg per dose,and when the recommended daily dose is not more than 240mg"2).